[en] A working party of the "Association d'Epidemiologie et de Sante Animale" assessed the strategy for a control of infectious bovine rhinotracheitis (IBR) in Belgium and studied its feasability and the different programmes to be applied. Epidemiology of IBR in Belgium, vaccination, diagnostic methods, economic aspects of IBR control, Belgian laws regarding IBR and the motivation of people in the field were described. The advantages and disadvantages of three programmes were analysed: to maintain the current situation, to protect cattle against clinical disease and to control and eradicate IBR.
Disciplines :
Microbiology Veterinary medicine & animal health
Author, co-author :
Limbourg, B.
Kerkhofs, P.
Massard, C.
Michelet, S.
Saegerman, Claude ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Epidémiologie et analyse des risques appl. aux sc. vétér.
Thiry, Etienne ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Virologie, épidémiologie et pathologie des maladies virales
Language :
French
Title :
Advantages and disadvantages of a control programme against infectious bovine rhinotracheitis in Belgium
Boelaert F., Biront P., Soumare B., Dispas M., Van Opdenbosch E., Vermeersch J.P., Raskin A., Dufey J., Berkvens D., Kerkhofs P. (2000) Prevalence of bovine herpesvirus 1 in the Belgian cattle population. Prev. Vet. Med. 45:285-295.
Bosch J.C. (1995) Resultaten van de veldproef met het IBR markervaccin. Symposium "Nederland op weg naar de IBR-vrije status", Deventer, 22 juin; .
Bosch J.C., Kaashoek M.J., Kroese A.H., Van Oirschot J.T. (1996) An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet. Microbiol. 52:223-234.
Bosch J.C., Frankena K., Van Oirschot J.T. (1997) Effect on milk production of vaccination with a bovine herpesvirus 1 gene-deleted vaccine. Vet. Rec. 140:196-199.
.
De Wit J.J., Hage J.J., Brinkhof J.M.A., Westenbrink F. (1998) A comparative study of serological tests for use in the bovine herpesvirus 1 eradication program in the Netherlands. Vet. Microbiol. 61:153-163.
Falcone E., Tollis M., Conti G. (1999) Bovine viral diarrhea disease associated with a contaminated vaccine. Vaccine 18:387-388.
Gogev S., Vanderheijden N., Lemaire M., Schynts, D'Offay J., Deprez I., Adam M., Eloit M., Thiry E. (2002) Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine 20:1451-1465.
Graat L., De Jong M., Frankena K. (1997) Qualification and monitoring of the IBR-free status. IBR control programmes. Qualification and monitoring of the IBR-free status , Gezondheidsdienst voor Dieren, Maastricht; 19-21.
Hage J.J., Schukken Y.H., Dijkstra Th., Barkema H.W., Van Valkengoed P.H.R., Wentink G.H. (1998) Milk production and reproduction during a subclinical bovine herpesvirus 1 infection on a dairy farm. Prev. Vet. Med. 34:97-106.
Hartman A., Van Wuijckhuise L., Frankena K., Franken P. (1997) Within-herd BOHV-1 prevalence prediction from an ELISA bulk milk. Vet. Rec. 140:484-485.
Kaashoek M.J., Moerman A., Madic J., Rijsewijk F.A., Quak J., Gielkens A.L., Van Oirschot J.T. (1994) A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12:439-444.
Kaashoek M.J., Moerman A., Madic J., Weerdmeester K., Maris-Veldhuis M., Rijsewijk F.A., Van Oirschot J.T. (1995) An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 13:342-346.
Kramps J.A., Magdalena J., Quak J., Weerdmeester K., Kaashoek M.J., Maris-Veldhuis M.A., Rijsewijk F.A., Keil G., Van Oirschot J.T. (1994) A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1. J. Clin. Microbiol. 32:2175-2181.
Lemaire M., Thiry E. (1995) Virological protection attempted by repeated vaccinations with inactivated vaccines directed against bovine herpesvirus 1 infection. Symposium on IBR and other ruminant herpesvirus infections , Sart Tilman, Belgium, 26-27 July; 52.
Lemaire M., Pastoret P.-P., Thiry E. (1994) Le contrôle de l'infection par le virus de la rhinotrachéite infectieuse bovine. Ann. Méd. Vét. 138:167-180.
Lemaire M., Meyer G., Ernst E., Vanherreweghe V., Limbourg B., Pastoret P.-P., Thiry E. (1995) Latent bovine herpesvirus 1 infection in calves protected by colostral immunity. Vet. Rec. 137:70-71.
Lemaire M., De Wergifosse B., Nols L., Limbourg B., Deblicquy P., Onclin M., Czaplicki G., Bughin J., Antoine H., Wellemans G., Pastoret P.-P., Thiry E. (1997) A study of the prevalence of bovine herpes virus 1 infection in the Walloon region of Belgium. Epidémiologie et Santé Animale , ISVEE Paris, AEEMA, 11.C21; (SPEC. ISSUE):31-32.
Lemaire M., Weynants V., Godfroid J., Schynts F., Meyer G., Letesson J.-J., Thiry E. (2000) Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency. J. Clin. Microbiol. 38:1885-1894.
Lemaire M., Meyer G., Baranowski E., Schynts F., Wellemans G., Kerkhofs P., Thiry E. (2000) Production of bovine herpesvirus type 1 sero-negative latent carriers by administration of a live-attenuated vaccine in passively immunized calves. J. Clin. Microbiol. 38:4233-4238.
Lemaire M., Schynts F., Meyer G., Georgin J.-P., Baranowski E., Gabriel A., Ros C., Belak S., Thiry E. (2001) Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: Influence of virus load and effect of specific maternal antibodies. Vaccine 19:4795-4804.
Mars M.H., De Jong M.C.M., Franken P., Van Oirschot J.T. (2001) Efficacy of a live gE-negative BHV1 vaccine in cattle in the field. Vaccine 19:1924-1930.
Arrêté royal du 23 janvier 1992 relatif aux conditions sanitaires de la collecte et du transfert des embryons de l'espèce bovine. Monit. Belg., 27.II.1992, erratum 19.VI.1992; .
Arrêté royal du 9 décembre 1992 portant des dispositions zootechniques et de police sanitaire vétérinaire concernant la production, le traitement, le stockage, l'usage, les échanges intracommunautaires et l'importation du sperme de bovin. Monit. Belg., 6.II.1993; .
Arrêté Royal du 8 août 1997 relatif à la qualification des troupeaux dans la lutte contre la rhinotrachéite infectieuse bovine. Monit. Belg., 30.VIII.1997; .
Pastoret P.-P., Thiry E., Brochier B., Derboven G., Vindevogel H. (1984) The role of latency in the epizootiology of infectious bovine rhinotracheitis. Latent herpesvirus infections in veterinary medicine , Wittmann G., Gaskell R.M., Rziha H.-J (Eds). Martinus Nijhoff Publishers, Boston; 221-227.
Pastoret P.-P., Detal G., Dive M., Waxweiler S., Thiry E., Wellemans G., Marcourt J., Magonet P., Dernelle E. (1989) Mesures à prendre au centre de sélection bovine de Ciney en vue de répondre aux nouvelles normes sanitaires imposes par le Commission des Communautés Européennes. Ann. Méd. Vét. 133:247-256.
Perrin B., Perrin M., Moussa A., Coudert M. (1996) Evaluation of a commercial gE blocking ELISA test for detection of antibodies to infectious bovine rhinotracheitis virus. Vet. Rec. 138:520.
Schynts F., Lemaire M., Baranowski E., Thiry E. (1998) La glycoprotéine gE de l'herpèsvirus bovin de type 1 et les nouveaux vaccins marqués. Ann. Méd. Vét. 142:21-32.
Schynts F., Vanderplasschen A., Hanon E., Rijsewijk F., Van Oirschot J.T., Thiry E. (2001) Use of PCR and double immunofluorescence staining to detect bovine herpesvirus type 1 recombinants. J. Virol. Methods 92:99-104.
Straub O.C. (1996) Experiences with two BHV-1 marker vaccines. Proceedings 19th World Buiatrics Congress , Edinburgh, United Kingdom, 8-12 July; 39-41.
Strube W., Auer S., Block W., Heinen E., Kretzdorn D., Rodenbach C., Schmeer N. (1996) A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. Vet. Microbiol. 53:181-189.
Thiry E., Pastoret P.-P., Dispas M., Hamers C., Lambot M., Lecomte C., Lemaire M., Schynts F., Vanderheijden N. (1997) Le rôle de la vaccination dans la prévention des maladies respiratoires d'origine virale chez les bovins. Les troubles respiratoires des bovins , Société française de Buiatrie; 278-299.
Thiry E., Lemaire M., Schynts F., Vanderheijden N., Meyer G., Dispas M., Pastoret P.-P. (1997) La rhinotrachéite infectieuse bovine: Caractéristiques du virus, de l'infection et ses manifestations cliniques. Bull. Group. Tech. Vet. , 4-B.-568; 7-16.
Thiry E., Lemaire M., Schynts F., Vanderheijden N., Meyer G., Dispas M., Pastoret P.-P. (1997) Les différents vaccins disponibles contre la rhinotrachéite infectieuse bovine. Bull. Group. Tech. Vet. , 4-B.-568; 69-75.
Thiry E., Lemaire M., Schynts F., Meyer G., Dispas M., Gogev S. (1999) Les conséquences de l'infection des bovins par le virus de la rhinotrachéite infectieuse bovine. Point Vét. 30:279-286.
Van Der Poel W.H.M., Hage J.J. (1998) Onderzoek naar spreiding van een intramusculair toegediend levend gE-negatief BHV1 marker vaccin op twee rundveebedrijven. Tijdschr. Diergeneesk. 123:109-111.
Van Malderen G., Van Opdenbosch E., Wellemans G. (1987) Bovien herpes virus 1 en 4: Een sero-epidemiologisch onderzoek van de Belgische rundveestapel. Vlaams. Diergeneeskd. Tijdschr. 4:364-371.
Van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A.M. (1996) Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet. Microbiol. 53:43-54.
Van Oirschot J.T., Kaashoek M.J., Marisveldhuis M.A., Weerdmeester K., Rijsewijk F.A.M. (1997) An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J. Virol. Methods 67:23-34.
Van Schaik G., Dijkhuizen A.A., Huirne R.B.M., Schukken Y.H., Nielen M., Hage H.J. (1998) Risks factors for existence of bovine herpesvirus 1 antibodies on nonvaccinating Dutch dairy farms. Prev. Vet. Med. 34:125-136.
Wellenberg G.J., Verstraten E.R.A.M., Mars M.H., Van Oirschot J.T. (1998) Detection of bovine herpesvirus 1 glycoprotein E antibodies in individual milk samples by enzyme linked immunosorbent assays. J. Clin. Microbiol. 36:409-413.
Wellenberg G.J., Verstraten E.R.A.M., Mars M.H., Van Oirschot J.T. (1998) ELISA detection of antibodies to glycoprotein E of bovine herpesvirus 1 in bulk milk samples. Vet. Rec. 142:219-220.
Wentink G.H., Van Oirschot J.T., Verhoeff J. (1993) Risk of infection with bovine herpesvirus-1 (BHV1) a review. Vet. Q. 15:30-33.
